drug

lunsekimig

1 story · latest Aug 28, 2026

Status: Investigational
Code: SAR443765
Trials: 6 registered trials in coverage

Relationships

Developed by Sanofi

Timeline

Sanofi registers Phase 3 extension study for lunsekimig in COPD, named COLOSSUS

Aug 28Trial updatelunsekimig Sanofi

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.